Vanda Pharmaceuticals (VNDA) Profit After Tax (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.60% |
| Dec 31, 2025 | -525.11% |
| Sep 30, 2025 | 16.98% |
| Jun 30, 2025 | 7.75% |
| Mar 31, 2025 | -500.45% |
| Dec 31, 2024 | 7.74% |
| Sep 30, 2024 | -17.84% |
| Jun 30, 2024 | -8.97% |
| Mar 31, 2024 | -72.75% |
| Dec 31, 2023 | -1,851.82% |
| Sep 30, 2023 | -90.99% |
| Jun 30, 2023 | -53.26% |
| Mar 31, 2023 | -52.60% |
| Dec 31, 2022 | 109.82% |
| Sep 30, 2022 | 27.04% |
| Jun 30, 2022 | 140.03% |
| Mar 31, 2022 | -190.84% |
| Dec 31, 2021 | -8.92% |
| Sep 30, 2021 | -19.50% |
| Jun 30, 2021 | 11.60% |
| Mar 31, 2021 | 5.62% |
| Dec 31, 2020 | 37.72% |
| Sep 30, 2020 | -31.75% |
| Jun 30, 2020 | 1,693.00% |
| Mar 31, 2020 | -88.47% |
| Dec 31, 2019 | -95.80% |
| Sep 30, 2019 | 771.27% |
| Jun 30, 2019 | 1,983.33% |
| Mar 31, 2019 | -105.91% |
| Dec 31, 2018 | 44.47% |
| Sep 30, 2018 | 55.52% |
| Jun 30, 2018 | 50.39% |
| Mar 31, 2018 | 266.81% |
| Dec 31, 2017 | 59.60% |
| Sep 30, 2017 | -196.61% |
| Jun 30, 2017 | 79.93% |
| Mar 31, 2017 | -1,165.73% |
| Dec 31, 2016 | -40.47% |
| Sep 30, 2016 | 90.69% |
| Jun 30, 2016 | 62.63% |
| Mar 31, 2016 | 16.48% |
| Dec 31, 2015 | -56.40% |
| Sep 30, 2015 | -75.66% |
| Jun 30, 2015 | 47.30% |
| Mar 31, 2015 | -114.66% |
| Dec 31, 2014 | 4,989.13% |
| Sep 30, 2014 | 93.39% |
| Jun 30, 2014 | 18.69% |
| Mar 31, 2014 | -242.49% |
| Dec 31, 2013 | -43.30% |
| Sep 30, 2013 | -59.80% |
| Jun 30, 2013 | 25.14% |
| Mar 31, 2013 | 29.05% |
| Dec 31, 2012 | -19.58% |
| Sep 30, 2012 | 33.48% |
| Jun 30, 2012 | -0.57% |
| Mar 31, 2012 | -44.16% |
| Dec 31, 2011 | -79.67% |
| Sep 30, 2011 | -129.23% |
| Jun 30, 2011 | -1,086.03% |
| Mar 31, 2011 | -93.82% |
| Dec 31, 2010 | -30.94% |
| Sep 30, 2010 | 148.75% |